Founded in 2006 by Dr. Andreas and Kirsi Schuessler, Acandis is a leading neurovascular medical device platform. With state-of-the-art manufacturing facilities and commercial operations in more than 60 countries, Acandis is fully vertically-integrated and rapidly growing. The company is headquartered in Pforzheim, Germany and employs more than 300 people.

Since its inception, under the leadership of its founders and management team, Acandis has demonstrated an aptitude for continuous innovation, establishing itself as a pioneer in the flow diverter, rescue stenting, mechanical thrombectomy and biologically-active device coating fields.

The company has launched 17 product families with an emphasis on improving patient outcomes and procedure ease. Because of Acandis product’s unique features and benefits, the company has achieved market leadership in multiple geographies. Excellence in stent design has enabled the company to produce an unprecedented range of device sizes, all seemingly tailor made to patient anatomy.